Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients — Stella

Home/Lung Transplant; Complications/Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

View on ClinicalTrials.gov

Recruiting

Back to Lung Transplant; Complications trials

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Phase

Very early testing

Sponsor

Vanderbilt University Medical Center

Collaborators

Veloxis Pharmaceuticals

Enrollment target

~48 participants

Started

December 2023

Primary completion

June 2026

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.